The re-expression of oncofetal antigens in cancerous tissues provides key insights into the pathogenesis and progression of tumors. Importantly, these antigens can be detected in blood, making them useful for non-invasive cancer screening and monitoring. Their presence can also have prognostic implications, aiding in the prediction of disease outcome.
